These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 7592952)
1. The turnover of cytoplasmic triacylglycerols in human fibroblasts involves two separate acyl chain length-dependent degradation pathways. Hilaire N; Salvayre R; Thiers JC; Bonnafé MJ; Nègre-Salvayre A J Biol Chem; 1995 Nov; 270(45):27027-34. PubMed ID: 7592952 [TBL] [Abstract][Full Text] [Related]
2. Cellular uptake and catabolism of high-density-lipoprotein triacylglycerols in human cultured fibroblasts: degradation block in neutral lipid storage disease. Hilaire N; Nègre-Salvayre A; Salvayre R Biochem J; 1994 Feb; 297 ( Pt 3)(Pt 3):467-73. PubMed ID: 8110183 [TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic triacylglycerols and cholesteryl esters are degraded in two separate catabolic pools in cultured human fibroblasts. Hilaire N; Nègre-Salvayre A; Salvayre R FEBS Lett; 1993 Aug; 328(3):230-4. PubMed ID: 8348969 [TBL] [Abstract][Full Text] [Related]
4. Metabolism of 1-pyrenedecanoic acid and accumulation of neutral fluorescent lipids in cultured fibroblasts of multisystemic lipid storage myopathy. Radom J; Salvayre R; Maret A; Nègre A; Douste-Blazy L Biochim Biophys Acta; 1987 Jul; 920(2):131-9. PubMed ID: 3607075 [TBL] [Abstract][Full Text] [Related]
5. Influence of chain length of pyrene fatty acids on their uptake and metabolism by Epstein-Barr-virus-transformed lymphoid cell lines from a patient with multisystemic lipid storage myopathy and from control subjects. Radom J; Salvayre R; Levade T; Douste-Blazy L Biochem J; 1990 Jul; 269(1):107-13. PubMed ID: 2165389 [TBL] [Abstract][Full Text] [Related]
6. Acylglycerol recycling from triacylglycerol to phospholipid, not lipase activity, is defective in neutral lipid storage disease fibroblasts. Igal RA; Coleman RA J Biol Chem; 1996 Jul; 271(28):16644-51. PubMed ID: 8663220 [TBL] [Abstract][Full Text] [Related]
7. Extracellular origin of the lipid lysosomal storage in cultured fibroblasts from Wolman's disease. Salvayre R; Negre A; Maret A; Radom J; Douste-Blazy L Eur J Biochem; 1987 Dec; 170(1-2):453-8. PubMed ID: 3691534 [TBL] [Abstract][Full Text] [Related]
8. Hydrolysis of fluorescent pyrenetriacylglycerols by lipases from human stomach and gastric juice. Nègre A; Salvayre R; Dousset N; Rogalle P; Dang QQ; Douste-Blazy L Biochim Biophys Acta; 1988 Nov; 963(2):340-8. PubMed ID: 3196738 [TBL] [Abstract][Full Text] [Related]
9. Independence of triacylglycerol-containing compartments in cultured fibroblasts from Wolman disease and multisystemic lipid storage myopathy. Salvayre R; Nègre A; Radom J; Douste-Blazy L FEBS Lett; 1989 Jun; 250(1):35-9. PubMed ID: 2737299 [TBL] [Abstract][Full Text] [Related]
10. Metabolism of neutral lipids in cultured fibroblasts from multisystemic (or type 3) lipid storage myopathy. Radom J; Salvayre R; Negre A; Maret A; Douste-Blazy L Eur J Biochem; 1987 May; 164(3):703-8. PubMed ID: 3569285 [TBL] [Abstract][Full Text] [Related]
11. Biochemical and ultrastructural features of human fibroblasts cultured from a new variant of type 3 lipid storage myopathy. Radom J; Salvayre R; Mussini JM; De Lisle B; Negre A; Maret A; Billaudel S; Douste-Blazy L Biol Cell; 1988; 62(1):39-45. PubMed ID: 3365518 [TBL] [Abstract][Full Text] [Related]
12. Heat stress deteriorates mitochondrial beta-oxidation of long-chain fatty acids in cultured fibroblasts with fatty acid beta-oxidation disorders. Li H; Fukuda S; Hasegawa Y; Purevsuren J; Kobayashi H; Mushimoto Y; Yamaguchi S J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1669-72. PubMed ID: 20207594 [TBL] [Abstract][Full Text] [Related]
13. Neutral lipid storage disease: a genetic disorder with abnormalities in the regulation of phospholipid metabolism. Igal RA; Coleman RA J Lipid Res; 1998 Jan; 39(1):31-43. PubMed ID: 9469583 [TBL] [Abstract][Full Text] [Related]
14. Neutral lipid storage disease with ichthyosis: lipid content and metabolism of fibroblasts. Williams ML; Monger DJ; Rutherford SL; Hincenbergs M; Rehfeld SJ; Grunfeld C J Inherit Metab Dis; 1988; 11(2):131-43. PubMed ID: 3139924 [TBL] [Abstract][Full Text] [Related]
15. Use of pyrenemethyl laurate for fluorescence-based determination of lipase activity in intact living lymphoblastoid cells and for the diagnosis of acid lipase deficiency. Nègre-Salvayre A; Dagan A; Gatt S; Salvayre R Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):885-91. PubMed ID: 8397511 [TBL] [Abstract][Full Text] [Related]
16. Neutral lipid storage disease: a possible functional defect in phospholipid- linked triacylglycerol metabolism. Williams ML; Coleman RA; Placezk D; Grunfeld C Biochim Biophys Acta; 1991 Feb; 1096(2):162-9. PubMed ID: 2001430 [TBL] [Abstract][Full Text] [Related]
17. Contribution of novel ATGL missense mutations to the clinical phenotype of NLSD-M: a strikingly low amount of lipase activity may preserve cardiac function. Tavian D; Missaglia S; Redaelli C; Pennisi EM; Invernici G; Wessalowski R; Maiwald R; Arca M; Coleman RA Hum Mol Genet; 2012 Dec; 21(24):5318-28. PubMed ID: 22990388 [TBL] [Abstract][Full Text] [Related]
19. Multisystem triglyceride storage disease is due to a specific defect in the degradation of endocellularly synthesized triglycerides. Di Donato S; Garavaglia B; Strisciuglio P; Borrone C; Andria G Neurology; 1988 Jul; 38(7):1107-10. PubMed ID: 3386830 [TBL] [Abstract][Full Text] [Related]
20. Triacylglycerol metabolism by lymphocytes and the effect of triacylglycerols on lymphocyte proliferation. Calder PC; Yaqoob P; Newsholme EA Biochem J; 1994 Mar; 298 Pt 3(Pt 3):605-11. PubMed ID: 8141773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]